Search News:
PROGRAMS
 
 
VIDEO: Genetic Variants Help Predict Obesity, Lucentis Outperforms PDT for Macular Degeneration Treatment, Moderate Alcohol Consumption Offers Benefits for Healthy Adults
VIDEO: Genetic Variants Help Predict Obesity, Lucentis Outperforms PDT for Macular Degeneration Treatment, Moderate Alcohol Consumption Offers Benefits for Healthy Adults

(January 19, 2009 - Insidermedicine) From London - According to research in the journal Nature Genetics, newly found genetic variants may help predict obesity. In a study of nearly 2,800 people, researchers discovered three genetic mutations that were significantly linked to obesity. The researchers suggest that these variants could account for up to 50% of cases of severe obesity. Further research could lead to new screening techniques to find out who is at highest risk of becoming obese.

From Baltimore - According to research in the Archives of Ophthalmology, Lucentis outperformed photodynamic therapy for the treatment of neovascular age-related macular degeneration. In a study of over 400 patients, researchers found that those treated monthly with 0.5 mg of Lucentis reported an improvement of 8.1 points on a visual function questionnaire, compared to those who underwent photodynamic therapy, who reported an improvement of only 2.2 points.

And finally, from Los Angeles - According to research in the American Journal of Epidemiology, light to moderate alcohol consumption may provide benefits for healthy older adults. In a study of over 4,200 people aged 50 and older, those who were healthy and drank fewer than 15 drinks per week had a 17% chance of becoming disabled or dying in 5 years, compared with 26% among those who did not drink. This benefit was not seen in those who rated their health as fair or poor.

For Insidermedicine in 60, I'm Dr. Susan Sharma.

 
OUR TEAM
More...  
EDITORIAL BOARD
More...